Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Month-Long Wait Times Caused by US Physician Shortage.

2.

Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment

3.

GLP-1 Receptor antagonists used in a study allay fears about thyroid cancer.

4.

a brand-new generic therapy for different types of cancer.

5.

Compared to previous estimates, a greater number of patients participate in cancer treatment trials.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot